Study reveals a current diagnosis of cancer increases the risk of severe COVID-19 outcomes in patients
A new study published in Cancer Epidemiology, Biomarkers, and Prevention has revealed that current cancer diagnosis in patients created a significant risk for severe covid-19 outcomes during the first two years, which also include ICU admission and death.
Elisa Tong, UC Davis Internist and Cancer Prevention Researcher said this study was the second largest, which included COVID-19 patients from across the United States. طاولة الروليت Moreover, the National Cancer Institute funded the study. لعبة بوكر اون لاين
She said,
This was the second-largest study of COVID-19 patients in the United States, and it was funded by the National Cancer Institute (NCI). The results showed that getting the COVID-19 vaccine significantly reduces the risk of death for cancer patients who develop COVID-19
Researchers from the University of Wisconsin lead the study. It included 104,590 patients at twenty-one healthy systems around the US. The sample comprised hospitalised patients diagnosed with covid from 1st February 2020 to 30th September 2021. Furthermore, 6.8% had been diagnosed with cancer currently and 6.5% had a history of cancer.
Tong said,
UC Davis was selected as one of the 21 health systems to contribute diverse patient data for this nationwide COVID-19 research. We have been part of the NCI Cancer Center Cessation Initiative since it began in 2017 and our skilful research informatics team was key in making it possible to join such an ambitious research initiative at the beginning of the COVID pandemic.
The cancers examined were leukaemia, prostate, multiple myeloma, lymphoma, breast, lung, and digestive. However, other than prostate cancer, all were associated with higher in-hospital mortality without a current or past history of cancer. Furthermore, a strong association was seen between metastatic and hematologic cancers corresponding to non-metastatic solid tumour cancers.
Senior author of the paper Wendy Slutske said,
An encouraging finding was that individuals with a past history of most types of cancer who were infected and hospitalized with COVID-19 were not at higher risk for severe outcomes, including death, compared to those with no current or past cancer history. This is an important and hopeful finding because cancer survivors represent an increasingly large segment of our population, due to advances in prevention, early detection and treatment.
Moreover, lead author Margaret Nolan commented further saying that although mortality decreased for COVID-19 itself, it increased the risk of complications in current cancer diagnosis patients.
While mortality and ICU admission rates for COVID-19 decreased during the course of the pandemic, the increased risk of current cancer on severe outcomes from COVID-19 remained constant across the first two years of the pandemic (2020 and 2021). لعبة على الانترنت
In circumstances where patients had been vaccinated prior to hospital admission, their risk of ICU admission and death decreased to some extent. Regardless of what the status of their cancer was. Moreover, patients with or without cancer benefit from vaccination.
Bottom Line
Tong further said that the bottom line is that cancer patients should be aware of how important it is to be fully vaccinated against COVID-19. Moreover, they should also be up-to-date with their boosters.
Bottom line, what’s important for current cancer patients to know is that it is critically important to be fully vaccinated against COVID-19 and up to date on your boosters.
